Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2020-05-27

AUTHORS

Ryunosuke Goto, Ryo Inuzuka, Takahiro Shindo, Yoshiyuki Namai, Yoichiro Oda, Yutaka Harita, Akira Oka

ABSTRACT

Introduction/objectivesThe dosing of intravenous immunoglobulin (IVIG) therapy for Kawasaki disease (KD) has been a matter of debate for decades, with recent studies implicating that larger doses lead to better outcomes. Despite this, few have investigated post-IVIG infusion immunoglobulin G (IgG) levels in relation to outcomes of KD such as response to IVIG and development of coronary artery abnormalities (CAAs). The present study investigated how varying levels of post-infusion IgG affected these outcomes.MethodWe collected demographic and laboratory data, including post-infusion IgG, from children with KD who were admitted to six hospitals in Japan between 2006 and 2012. We conducted multivariate analyses to examine the relationship between independent variables and non-response to IVIG and development of CAAs. We used random forest, a decision tree-based machine learning tool, to investigate the marginal effect of varying post-infusion IgG levels on non-response to IVIG and development of CAAs.ResultsOf 456 patients included in the study, 130 (28.5%) were non-responders and 38 (8.3%) developed CAAs. Sodium, post-infusion IgG, and AST were significantly associated with non-response. Post-infusion IgG and sodium were significantly associated with CAA development. The random forest plots revealed a decrease in non-response and CAA rates with increasing post-infusion IgG until post-infusion IgG was near the median (2821 mg/dL), after which the non-response and CAA rates leveled off.ConclusionsGreater post-infusion IgG is associated with better response to IVIG and decreased CAA development in KD patients, but this effect levels off at post-infusion IgG levels greater than the median.Key points• Though previous studies have shown that post-intravenous immunoglobulin (IVIG) infusion immunoglobulin G (IgG) is associated with non-response to IVIG therapy and coronary artery abnormality (CAA) development in Kawasaki disease (KD) patients, no study has investigated the relationship between varying levels of post-infusion IgG and these clinical outcomes.• Our study showed that non-response to IVIG therapy and CAA development in Kawasaki disease patients follow a decreasing trend with increasing post-infusion IgG at post-infusion IgG levels below the median.• At values of post-infusion IgG greater than the median, non-response and CAA development rates remain relatively constant with increasing post-infusion IgG.• Our study suggests that when post-infusion IgG is greater than the median, IgG may have fully bound to the therapeutic targets of KD, and in these patients, there may be limited benefit in administering additional IVIG. More... »

PAGES

3747-3755

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-020-05153-w

DOI

http://dx.doi.org/10.1007/s10067-020-05153-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1127892005

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32458247


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulins, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mucocutaneous Lymph Node Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412708.8", 
          "name": [
            "Department of Pediatrics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goto", 
        "givenName": "Ryunosuke", 
        "id": "sg:person.014410615773.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014410615773.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inuzuka", 
        "givenName": "Ryo", 
        "id": "sg:person.0754703647.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754703647.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Department of Medical Subspecialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, 157-0074, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.63906.3a", 
          "name": [
            "Division of Cardiology, Department of Medical Subspecialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, 157-0074, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shindo", 
        "givenName": "Takahiro", 
        "id": "sg:person.01265433710.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265433710.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, Koriyama, 963-8558, Fukushima, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416783.f", 
          "name": [
            "Department of Pediatrics, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, Koriyama, 963-8558, Fukushima, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Namai", 
        "givenName": "Yoshiyuki", 
        "id": "sg:person.01117626343.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117626343.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Chigasaki Municipal Hospital, 5-15-1 Honson, Chigasaki, 253-0042, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pediatrics, Chigasaki Municipal Hospital, 5-15-1 Honson, Chigasaki, 253-0042, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oda", 
        "givenName": "Yoichiro", 
        "id": "sg:person.01127465327.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127465327.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harita", 
        "givenName": "Yutaka", 
        "id": "sg:person.01150460037.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150460037.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oka", 
        "givenName": "Akira", 
        "id": "sg:person.01313574400.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313574400.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/11538910-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035753360", 
          "https://doi.org/10.2165/11538910-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00431-006-0223-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002335791", 
          "https://doi.org/10.1007/s00431-006-0223-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-018-4339-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107733176", 
          "https://doi.org/10.1007/s10067-018-4339-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-0-387-21606-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022356842", 
          "https://doi.org/10.1007/978-0-387-21606-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-05-27", 
    "datePublishedReg": "2020-05-27", 
    "description": "Introduction/objectivesThe dosing of intravenous immunoglobulin (IVIG) therapy for Kawasaki disease (KD) has been a matter of debate for decades, with recent studies implicating that larger doses lead to better outcomes. Despite this, few have investigated post-IVIG infusion immunoglobulin G (IgG) levels in relation to outcomes of KD such as response to IVIG and development of coronary artery abnormalities (CAAs). The present study investigated how varying levels of post-infusion IgG affected these outcomes.MethodWe collected demographic and laboratory data, including post-infusion IgG, from children with KD who were admitted to six hospitals in Japan between 2006 and 2012. We conducted multivariate analyses to examine the relationship between independent variables and non-response to IVIG and development of CAAs. We used random forest, a decision tree-based machine learning tool, to investigate the marginal effect of varying post-infusion IgG levels on non-response to IVIG and development of CAAs.ResultsOf 456 patients included in the study, 130 (28.5%) were non-responders and 38 (8.3%) developed CAAs. Sodium, post-infusion IgG, and AST were significantly associated with non-response. Post-infusion IgG and sodium were significantly associated with CAA development. The random forest plots revealed a decrease in non-response and CAA rates with increasing post-infusion IgG until post-infusion IgG was near the median (2821\u00a0mg/dL), after which the non-response and CAA rates leveled off.ConclusionsGreater post-infusion IgG is associated with better response to IVIG and decreased CAA development in KD patients, but this effect levels off at post-infusion IgG levels greater than the median.Key points\u2022 Though previous studies have shown that post-intravenous immunoglobulin (IVIG) infusion immunoglobulin G (IgG) is associated with non-response to IVIG therapy and coronary artery abnormality (CAA) development in Kawasaki disease (KD) patients, no study has investigated the relationship between varying levels of post-infusion IgG and these clinical outcomes.\u2022 Our study showed that non-response to IVIG therapy and CAA development in Kawasaki disease patients follow a decreasing trend with increasing post-infusion IgG at post-infusion IgG levels below the median.\u2022 At values of post-infusion IgG greater than the median, non-response and CAA development rates remain relatively constant with increasing post-infusion IgG.\u2022 Our study suggests that when post-infusion IgG is greater than the median, IgG may have fully bound to the therapeutic targets of KD, and in these patients, there may be limited benefit in administering additional IVIG.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-020-05153-w", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "keywords": [
      "coronary artery abnormalities", 
      "Kawasaki disease patients", 
      "development of CAA", 
      "Kawasaki disease", 
      "IgG levels", 
      "CAA development", 
      "disease patients", 
      "clinical outcomes", 
      "outcomes of KD", 
      "intravenous immunoglobulin therapy", 
      "immunoglobulin G levels", 
      "mechanism of action", 
      "immunoglobulin therapy", 
      "additional IVIG", 
      "random forest plots", 
      "KD patients", 
      "IVIG", 
      "large doses", 
      "better outcomes", 
      "patients", 
      "therapeutic target", 
      "multivariate analysis", 
      "matter of debate", 
      "IgG", 
      "therapy", 
      "immunoglobulin G", 
      "laboratory data", 
      "median", 
      "outcomes", 
      "good response", 
      "present study", 
      "Recent studies", 
      "levels", 
      "previous studies", 
      "dosing", 
      "study", 
      "hospital", 
      "AST", 
      "disease", 
      "abnormalities", 
      "sodium", 
      "doses", 
      "forest plots", 
      "response", 
      "MethodWe", 
      "rate", 
      "children", 
      "independent variables", 
      "marginal effect", 
      "effect", 
      "development", 
      "new insights", 
      "relationship", 
      "development rate", 
      "decrease", 
      "target", 
      "action", 
      "benefits", 
      "mechanism", 
      "data", 
      "variables", 
      "tree-based machine", 
      "decades", 
      "Japan", 
      "analysis", 
      "trends", 
      "decision tree-based machine", 
      "tool", 
      "values", 
      "insights", 
      "relation", 
      "matter", 
      "random forest", 
      "debate", 
      "plots", 
      "machine", 
      "forest", 
      "Introduction/objectivesThe dosing", 
      "objectivesThe dosing", 
      "post-IVIG infusion immunoglobulin G (IgG) levels", 
      "infusion immunoglobulin G (IgG) levels", 
      "G (IgG) levels", 
      "artery abnormalities", 
      "post-infusion IgG", 
      "post-infusion IgG levels", 
      "ResultsOf 456 patients", 
      "CAA rates", 
      "ConclusionsGreater post-infusion IgG", 
      "post-intravenous immunoglobulin (IVIG) infusion immunoglobulin G", 
      "immunoglobulin (IVIG) infusion immunoglobulin G", 
      "infusion immunoglobulin G", 
      "coronary artery abnormality (CAA) development", 
      "artery abnormality (CAA) development", 
      "abnormality (CAA) development", 
      "CAA development rates", 
      "post-IVIG IgG levels"
    ], 
    "name": "Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG", 
    "pagination": "3747-3755", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1127892005"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-020-05153-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32458247"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-020-05153-w", 
      "https://app.dimensions.ai/details/publication/pub.1127892005"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_856.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-020-05153-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-020-05153-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-020-05153-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-020-05153-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-020-05153-w'


 

This table displays all metadata directly associated to this object as RDF triples.

264 TRIPLES      22 PREDICATES      135 URIs      123 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-020-05153-w schema:about N01896294b3794bb7bacdf5c68d5d8751
2 N11e621f84f7e464ba7831fde89519b39
3 N16a1bb8e24a54311b0f32376bc1ff5eb
4 N2d363d2aac1748b39a2c60bc657e47a9
5 N4ade441936a948979324b2aec7d9506d
6 N6d370f57e926482baa993446d575dfce
7 Nc745ca1b788441db96411762650c4f43
8 Nc93ab8b3477c4022898bff216717158c
9 Neab02dba73d64518bc28636cd47cb109
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author Ne96706c8fa084b2f854e5a84d298ea6e
13 schema:citation sg:pub.10.1007/978-0-387-21606-5
14 sg:pub.10.1007/s00431-006-0223-z
15 sg:pub.10.1007/s10067-018-4339-0
16 sg:pub.10.2165/11538910-000000000-00000
17 schema:datePublished 2020-05-27
18 schema:datePublishedReg 2020-05-27
19 schema:description Introduction/objectivesThe dosing of intravenous immunoglobulin (IVIG) therapy for Kawasaki disease (KD) has been a matter of debate for decades, with recent studies implicating that larger doses lead to better outcomes. Despite this, few have investigated post-IVIG infusion immunoglobulin G (IgG) levels in relation to outcomes of KD such as response to IVIG and development of coronary artery abnormalities (CAAs). The present study investigated how varying levels of post-infusion IgG affected these outcomes.MethodWe collected demographic and laboratory data, including post-infusion IgG, from children with KD who were admitted to six hospitals in Japan between 2006 and 2012. We conducted multivariate analyses to examine the relationship between independent variables and non-response to IVIG and development of CAAs. We used random forest, a decision tree-based machine learning tool, to investigate the marginal effect of varying post-infusion IgG levels on non-response to IVIG and development of CAAs.ResultsOf 456 patients included in the study, 130 (28.5%) were non-responders and 38 (8.3%) developed CAAs. Sodium, post-infusion IgG, and AST were significantly associated with non-response. Post-infusion IgG and sodium were significantly associated with CAA development. The random forest plots revealed a decrease in non-response and CAA rates with increasing post-infusion IgG until post-infusion IgG was near the median (2821 mg/dL), after which the non-response and CAA rates leveled off.ConclusionsGreater post-infusion IgG is associated with better response to IVIG and decreased CAA development in KD patients, but this effect levels off at post-infusion IgG levels greater than the median.Key points• Though previous studies have shown that post-intravenous immunoglobulin (IVIG) infusion immunoglobulin G (IgG) is associated with non-response to IVIG therapy and coronary artery abnormality (CAA) development in Kawasaki disease (KD) patients, no study has investigated the relationship between varying levels of post-infusion IgG and these clinical outcomes.• Our study showed that non-response to IVIG therapy and CAA development in Kawasaki disease patients follow a decreasing trend with increasing post-infusion IgG at post-infusion IgG levels below the median.• At values of post-infusion IgG greater than the median, non-response and CAA development rates remain relatively constant with increasing post-infusion IgG.• Our study suggests that when post-infusion IgG is greater than the median, IgG may have fully bound to the therapeutic targets of KD, and in these patients, there may be limited benefit in administering additional IVIG.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N32a13826406040e39b9bfeb26b929629
24 Nee0ebdccf36c4f6a978f18178ccfb019
25 sg:journal.1093299
26 schema:keywords AST
27 CAA development
28 CAA development rates
29 CAA rates
30 ConclusionsGreater post-infusion IgG
31 G (IgG) levels
32 IVIG
33 IgG
34 IgG levels
35 Introduction/objectivesThe dosing
36 Japan
37 KD patients
38 Kawasaki disease
39 Kawasaki disease patients
40 MethodWe
41 Recent studies
42 ResultsOf 456 patients
43 abnormalities
44 abnormality (CAA) development
45 action
46 additional IVIG
47 analysis
48 artery abnormalities
49 artery abnormality (CAA) development
50 benefits
51 better outcomes
52 children
53 clinical outcomes
54 coronary artery abnormalities
55 coronary artery abnormality (CAA) development
56 data
57 debate
58 decades
59 decision tree-based machine
60 decrease
61 development
62 development of CAA
63 development rate
64 disease
65 disease patients
66 doses
67 dosing
68 effect
69 forest
70 forest plots
71 good response
72 hospital
73 immunoglobulin (IVIG) infusion immunoglobulin G
74 immunoglobulin G
75 immunoglobulin G levels
76 immunoglobulin therapy
77 independent variables
78 infusion immunoglobulin G
79 infusion immunoglobulin G (IgG) levels
80 insights
81 intravenous immunoglobulin therapy
82 laboratory data
83 large doses
84 levels
85 machine
86 marginal effect
87 matter
88 matter of debate
89 mechanism
90 mechanism of action
91 median
92 multivariate analysis
93 new insights
94 objectivesThe dosing
95 outcomes
96 outcomes of KD
97 patients
98 plots
99 post-IVIG IgG levels
100 post-IVIG infusion immunoglobulin G (IgG) levels
101 post-infusion IgG
102 post-infusion IgG levels
103 post-intravenous immunoglobulin (IVIG) infusion immunoglobulin G
104 present study
105 previous studies
106 random forest
107 random forest plots
108 rate
109 relation
110 relationship
111 response
112 sodium
113 study
114 target
115 therapeutic target
116 therapy
117 tool
118 tree-based machine
119 trends
120 values
121 variables
122 schema:name Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG
123 schema:pagination 3747-3755
124 schema:productId N6f9fd887814142049ecc7e696201cf3d
125 Nb145810bc80f49898f20712892f4e50f
126 Nc86e692a2443460bbbf10b1c97b7d85c
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1127892005
128 https://doi.org/10.1007/s10067-020-05153-w
129 schema:sdDatePublished 2022-01-01T18:59
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher Nd7a946302b494931b0acee46c9114fbb
132 schema:url https://doi.org/10.1007/s10067-020-05153-w
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N01896294b3794bb7bacdf5c68d5d8751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 N0f969d89737440a9a692d664a7946079 rdf:first sg:person.01265433710.17
140 rdf:rest Ne4bec12b3d0b4195a30af548d716320d
141 N1148a80728534dbf9ff40a5eadbabba8 rdf:first sg:person.01150460037.33
142 rdf:rest N90d859510b6f48acb3d51de7e3d8bd47
143 N11e621f84f7e464ba7831fde89519b39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Infant
145 rdf:type schema:DefinedTerm
146 N16a1bb8e24a54311b0f32376bc1ff5eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Mucocutaneous Lymph Node Syndrome
148 rdf:type schema:DefinedTerm
149 N2d363d2aac1748b39a2c60bc657e47a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Japan
151 rdf:type schema:DefinedTerm
152 N32a13826406040e39b9bfeb26b929629 schema:issueNumber 12
153 rdf:type schema:PublicationIssue
154 N4ade441936a948979324b2aec7d9506d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Immunoglobulin G
156 rdf:type schema:DefinedTerm
157 N4b9fc65fa2e4432a8ad07a719b1d7986 rdf:first sg:person.0754703647.73
158 rdf:rest N0f969d89737440a9a692d664a7946079
159 N6bfeaeb3e696476a94b3d6bc3d6d433c rdf:first sg:person.01127465327.13
160 rdf:rest N1148a80728534dbf9ff40a5eadbabba8
161 N6d370f57e926482baa993446d575dfce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Immunoglobulins, Intravenous
163 rdf:type schema:DefinedTerm
164 N6f9fd887814142049ecc7e696201cf3d schema:name doi
165 schema:value 10.1007/s10067-020-05153-w
166 rdf:type schema:PropertyValue
167 N90d859510b6f48acb3d51de7e3d8bd47 rdf:first sg:person.01313574400.44
168 rdf:rest rdf:nil
169 Nb145810bc80f49898f20712892f4e50f schema:name dimensions_id
170 schema:value pub.1127892005
171 rdf:type schema:PropertyValue
172 Nc745ca1b788441db96411762650c4f43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Immunologic Factors
174 rdf:type schema:DefinedTerm
175 Nc86e692a2443460bbbf10b1c97b7d85c schema:name pubmed_id
176 schema:value 32458247
177 rdf:type schema:PropertyValue
178 Nc93ab8b3477c4022898bff216717158c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Retrospective Studies
180 rdf:type schema:DefinedTerm
181 Nd7a946302b494931b0acee46c9114fbb schema:name Springer Nature - SN SciGraph project
182 rdf:type schema:Organization
183 Ne4bec12b3d0b4195a30af548d716320d rdf:first sg:person.01117626343.06
184 rdf:rest N6bfeaeb3e696476a94b3d6bc3d6d433c
185 Ne96706c8fa084b2f854e5a84d298ea6e rdf:first sg:person.014410615773.24
186 rdf:rest N4b9fc65fa2e4432a8ad07a719b1d7986
187 Neab02dba73d64518bc28636cd47cb109 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Child
189 rdf:type schema:DefinedTerm
190 Nee0ebdccf36c4f6a978f18178ccfb019 schema:volumeNumber 39
191 rdf:type schema:PublicationVolume
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
196 schema:name Cardiorespiratory Medicine and Haematology
197 rdf:type schema:DefinedTerm
198 sg:journal.1093299 schema:issn 0770-3198
199 1434-9949
200 schema:name Clinical Rheumatology
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01117626343.06 schema:affiliation grid-institutes:grid.416783.f
204 schema:familyName Namai
205 schema:givenName Yoshiyuki
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117626343.06
207 rdf:type schema:Person
208 sg:person.01127465327.13 schema:affiliation grid-institutes:None
209 schema:familyName Oda
210 schema:givenName Yoichiro
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127465327.13
212 rdf:type schema:Person
213 sg:person.01150460037.33 schema:affiliation grid-institutes:grid.26999.3d
214 schema:familyName Harita
215 schema:givenName Yutaka
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150460037.33
217 rdf:type schema:Person
218 sg:person.01265433710.17 schema:affiliation grid-institutes:grid.63906.3a
219 schema:familyName Shindo
220 schema:givenName Takahiro
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265433710.17
222 rdf:type schema:Person
223 sg:person.01313574400.44 schema:affiliation grid-institutes:grid.26999.3d
224 schema:familyName Oka
225 schema:givenName Akira
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313574400.44
227 rdf:type schema:Person
228 sg:person.014410615773.24 schema:affiliation grid-institutes:grid.412708.8
229 schema:familyName Goto
230 schema:givenName Ryunosuke
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014410615773.24
232 rdf:type schema:Person
233 sg:person.0754703647.73 schema:affiliation grid-institutes:grid.26999.3d
234 schema:familyName Inuzuka
235 schema:givenName Ryo
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754703647.73
237 rdf:type schema:Person
238 sg:pub.10.1007/978-0-387-21606-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022356842
239 https://doi.org/10.1007/978-0-387-21606-5
240 rdf:type schema:CreativeWork
241 sg:pub.10.1007/s00431-006-0223-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1002335791
242 https://doi.org/10.1007/s00431-006-0223-z
243 rdf:type schema:CreativeWork
244 sg:pub.10.1007/s10067-018-4339-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107733176
245 https://doi.org/10.1007/s10067-018-4339-0
246 rdf:type schema:CreativeWork
247 sg:pub.10.2165/11538910-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035753360
248 https://doi.org/10.2165/11538910-000000000-00000
249 rdf:type schema:CreativeWork
250 grid-institutes:None schema:alternateName Department of Pediatrics, Chigasaki Municipal Hospital, 5-15-1 Honson, Chigasaki, 253-0042, Kanagawa, Japan
251 schema:name Department of Pediatrics, Chigasaki Municipal Hospital, 5-15-1 Honson, Chigasaki, 253-0042, Kanagawa, Japan
252 rdf:type schema:Organization
253 grid-institutes:grid.26999.3d schema:alternateName Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan
254 schema:name Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan
255 rdf:type schema:Organization
256 grid-institutes:grid.412708.8 schema:alternateName Department of Pediatrics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
257 schema:name Department of Pediatrics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
258 rdf:type schema:Organization
259 grid-institutes:grid.416783.f schema:alternateName Department of Pediatrics, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, Koriyama, 963-8558, Fukushima, Japan
260 schema:name Department of Pediatrics, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, Koriyama, 963-8558, Fukushima, Japan
261 rdf:type schema:Organization
262 grid-institutes:grid.63906.3a schema:alternateName Division of Cardiology, Department of Medical Subspecialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, 157-0074, Tokyo, Japan
263 schema:name Division of Cardiology, Department of Medical Subspecialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, 157-0074, Tokyo, Japan
264 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...